CD8A and cancer: The ideal goal of CD8+ TEXs reinvigoration is to boost anti-tumor immunity as much as possible, without causing immune-related tissue damage, prolong survival, suppress terminal exhaustion differentiation and contribute to the achievement of tumor elimination and better clinical outcomes in cancer patients.